Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Crohn Disease × Adalimumab × Clear all

Phase

Phase 4 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Psoriasis 2 Spondylitis, Ankylosing 1 Plaque Psoriasis 1 Osteoarthritis 1 Crohn Disease 1 Colitis, Ulcerative 1

Interventions

Certolizumab Pegol 5 Ringer's Lactate 1 Infliximab 1 Hydroxyethyl Starch Derivatives 1 Blood Specimen Collection 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02499783 2019-01-04

Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's Disease

AbbVie

Phase 3 Completed

205 enrolled 39 charts

Crohn Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡